About Preceptis Medical
Preceptis Medical is a private company based in Golden Valley, Minnesota. It has reported $22,939,860 raised in 11 offerings on Form D since December 2011. Its chief executive is David Carey.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | May 1, 2026 | $2,561,370of $6.9M target | 27 | $94,866 | EquityRule 506(b) | Form D ↗ |
| Dec 31, 2024 | Jan 15, 2025 | $2,000,000of $5.0M target | 1 | $2.0M | Debt, Options, Debt convertible into Common Stock or Preferred StockRule 506(b) | Form D ↗ |
| Jan 23, 2023 | Feb 7, 2023 | $4,499,996of $7.0M target | 2 | $2.2M | Equity, Series C Preferred StockRule 506(b) | Form D ↗ |
| Nov 30, 2020 | Dec 10, 2020amended Feb 5, 2021 | $3,882,253fully sold | 20 | $194K | Equity, Series B1 Preferred StockRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 16, 2018 | Jan 19, 2018amended Mar 12, 2020 | $3,671,244of $9.0M target | 26 | $141K | Equity, Series B Preferred StockRule 506(b) | Form D/A ↗2 earlier filings |
| Dec 12, 2017 | Dec 26, 2017 | $376,895of $384K target | 78 | $4,832 | Debt, Options, Issuance of Series B Preferred Stock in connection with conversion of convertible promissory issued in 2015, 2016 and 2017Rule 506(b) | Form D ↗ |
| Not yet | Aug 8, 2017 | $0of $1.0M target | 0 | — | Debt, Options, senior convertible promissory notes and warrantsRule 506(b) | Form D ↗ |
| Jun 14, 2016 | Jun 27, 2016 | $90,000of $3.0M target | 3 | $30,000 | Debt, Options, convertible promissory notesRule 506(b) | Form D ↗ |
| May 29, 2015 | Jun 10, 2015 | $976,000of $1.3M target | 17 | $57,412 | Debt, Options, Debt convertible into Series A Preferred StockRule 506(b) | Form D ↗ |
| Jan 29, 2014 | Jan 31, 2014 | $4,382,102fully sold | 34 | $128K | Equity, Securities on exercise, Series A Preferred StockRule 506(b) | Form D ↗ |
| Dec 7, 2011 | Dec 22, 2011 | $500,000of $2.5M target | 4 | $125K | Debt, Convertible Promissory Notes06 | Form D ↗ |
| Total, 11 offerings | $22,939,860 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Preceptis Medical's Form D filed May 1, 2026.
Earlier filings also listed Zhaohua Yuan (director, last listed Jan 2025), Steve Anderson (president and chief executive officer, director, last listed Jan 2025), Joe Delgado (executive officer, last listed Jan 2025), Feng Jiang (director, last listed Jan 2025), Toni Baraga (executive officer, last listed Dec 2017), Mark Wagner (director, last listed Aug 2017), Thomas Vettel (director and promoter, last listed Jun 2016) and Michael Dale (director and promoter, last listed Jun 2016).